Healthy individuals Not Applicable
Conditions
Interventions
Co-administration of 20 g of protein (vegetable protein isolated from yellow pea (Pisum Sativum), NUTRALYS® S85F, Roquette Freres S.A., France) with either 10 billion CFU of a multi-strain probiotic (
Sponsors
Sofar (Italy)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Healthy men between the ages of 18–35 years 2. Normal body weight (body mass index (BMI) of 19 – 24.99 kg/m²) 3. Recreationally active (according to American College of Sports Medicine Guidelines) 4. Subjects were not allowed to consume any nutritional or ergogenic supplement known to affect measures of the current study for the prior six weeks, including probiotics, prebiotics and digestive enzymes
Exclusion criteria
Exclusion criteria: 1. Currently being treated for or diagnosed with a gastrointestinal, cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, psychiatric, hematological, neurological or endocrinological disorder 2. Not weight stable defined as measured body mass deviating by 2% or more 3. Not willing to abstain from alcohol, nicotine, and caffeine for 12 hours prior to each visit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma amino acid concentrations measured using tandem-mass spectrometry (LC/MS/MS) at baseline, 30, 60, 120, and 180 minutes post-ingestion | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events throughout the study measured using case report forms | — |
Countries
United States of America
Outcome results
None listed